LFA
HAE icon

LGT Financial Advisors’s Haemonetics HAE Stock Holding History

LGT Financial Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31
Closed -$2.78K – 903
2023
Q3 		$2.78K Buy
+31
New +$2.77K ﹤0.01% 744

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LGT Financial Advisors's HAE Position: Q4 2023 in Review

LGT Financial Advisors sold out of Haemonetics (HAE) in Q4 2023, closing a stake of 31 shares — an estimated $2.78K sold.

LGT Financial Advisors first reported a position in HAE in Q3 2023 and held it in 1 quarter. The position peaked at $2.78K in Q3 2023. 295 funds tracked by Wall St. Rank hold HAE as of Q4 2023.

  • LGT Financial Advisors reported no remaining Haemonetics position as of Q4 2023 after selling out during the quarter.
  • LGT Financial Advisors sold 31 Haemonetics shares in Q4 2023, an estimated $2.78K.
  • LGT Financial Advisors first reported a position in Haemonetics in Q3 2023 and held it in 1 quarter.
  • LGT Financial Advisors's Haemonetics position peaked at $2.78K in Q3 2023.
  • 295 funds tracked by Wall St. Rank held Haemonetics as of Q4 2023.

Based on LGT Financial Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.